XOMA Earns $9 Million Milestone as FDA Grants Accelerated Approval to Day One’s OJEMDATM (tovorafenib) for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG)
April 25, 2024
Biotechnology
-
-
INmune Bio Inc. Announces $9.7 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
April 25, 2024
-
MAIA Biotechnology Announces $1.00 Million Private Placement
April 23, 2024
-
Nutriband Inc. Signs Exclusive Supplier Agreement with Major Sports Brand Licensee Fit for Life Group
April 23, 2024
-
Nutriband Inc. Announces $8.4M Private Placement
April 19, 2024
-
Benitec Biopharma Announces Oversubscribed Private Placement Financing of $40.0 Million
April 18, 2024
-
Lexaria Receives Ethics Review Board Approval to Begin New GLP-1 Study
April 16, 2024
-
SciSparc to Acquire AutoMax
April 11, 2024
-
NKGen Biotech Secures Additional Financing of $5 Million to Continue Advancing Its Clinical Programs
April 11, 2024
-
MariMed Closes Acquisition of Thrive Dispensary in Casey, The Company’s Fifth Illinois Dispensary
April 11, 2024
-
FDA Grants Soligenix Orphan Drug Designation for the Prevention and Post-Exposure Prophylaxis Against Sudan Ebolavirus Infection
April 11, 2024
-
Oncolytics Biotech® Advances Toward Registration-Enabling Trial for Pelareorep in Breast Cancer with Submission of Type C Meeting Request to FDA
April 11, 2024
-
Century Therapeutics Strengthens Position in Autoimmune Disease with Strategic Pipeline Expansion Supported by $60 Million Private Placement and Acquisition of Clade Therapeutics
April 11, 2024
-
BrainStorm Cell Therapeutics Regains Compliance with NASDAQ Minimum Market Value Rule
April 11, 2024
-
Aptevo Therapeutics Announces Pricing of $4.6 Million Public Offering
April 11, 2024
-
TRACON Pharmaceuticals Announces Reverse Stock Split
April 8, 2024